查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945472

2026年全球左心室輔助裝置市場報告

Left Ventricular Assist Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，左心室輔助裝置市場顯著擴張，預計將從2025年的17.3億美元成長到2026年的19億美元，複合年成長率達9.7%。過去幾年的成長可歸因於多種因素，包括晚期心臟衰竭患者數量的增加、供體心臟供不應求、專業心臟護理中心的擴張、外科移植技術的改進以及機械循環輔助裝置在臨床上的接受度不斷提高。

預計未來幾年，左心室輔助裝置（LVAD）市場將快速成長，到2030年市場規模將達到27.8億美元，複合年成長率（CAGR）為10.0%。預測期內的成長要素包括：患有心臟病的老年人口不斷成長、對長期心臟衰竭管理解決方案的需求不斷成長、生物相容性材料的進步、遠端監測技術的日益普及以及LVAD報銷範圍的擴大。預測期內的主要趨勢包括：連續流LVAD的普及率不斷提高、LVAD作為最後治療手段的應用日益廣泛、對小型化植入式泵的關注度不斷提升、遠端患者監護能力的增強以及對裝置耐用性和使用壽命的日益重視。

預計未來醫療費用支出的成長將推動左心室輔助裝置市場的發展。醫療費用支出涵蓋所有與醫療服務、計劃生育、營養計劃和以健康為中心的緊急援助相關的費用。醫療費用支出的成長推動了包括左心室輔助裝置在內的各種醫療保健相關產品的進步和發展。預計醫療費用支出的成長將對左心室輔助裝置市場的成長產生積極影響。例如，根據美國醫療保險和醫療補助服務中心 (CMS) 於 2025 年 6 月發布的數據，到 2023 年，全國醫療保健支出將成長 7.5%，達到 4.9 兆美元，占美國國內生產總值(GDP) 的 17.6%。因此，醫療保健支出的成長正在推動左心室輔助裝置市場的成長。

左心室輔助裝置領域的企業正致力於開發下一代技術，以取代傳統的旋轉式左心室輔助裝置（LVAD），尤其是基於波膜的系統。波膜解決方案旨在模擬天然心臟的搏動性和血流動力學，從而有可能複製健康心臟的功能，並減少與連續流裝置相關的併發症。例如，2025年9月，總部位於法國的醫療設備製造商CorWave SA在雪梨聖文森特醫院成功為首例病患植入了其左心室輔助系統（LVAS）。該系統透過有效減輕左心室負荷，同時維持25.5 ± 6.1 mmHg的主動脈脈壓，實現了完全的心臟支持，從而確保了主動脈瓣的穩定開放。該裝置達到了其主要終點，在30天內未發生任何與裝置相關的不利事件，患者在接受84天的支持後成功進行了心臟移植手術。這項進展代表了能夠提供安全、生理性搏動血流的連續機械循環支援裝置領域的重大進步。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球左心室輔助裝置市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
  • 主要趨勢
    • 持續流左心室輔助裝置（LVAD）的採用率不斷提高
    • 左心室輔助裝置（LVAD）作為最後治療手段的使用日益增多
    • 人們對小型化植入幫浦的興趣日益濃厚
    • 擴展遠端患者監護能力
    • 更加重視設備的耐用性和使用壽命

第5章 終端用戶產業市場分析

  • 醫院
  • 心臟病中心
  • 心臟診所
  • 心臟移植中心
  • 高級心臟衰竭診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球左心室輔助裝置市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球左心室輔助裝置市場規模、對比及成長率分析
  • 全球左心室輔助裝置市場表現：規模與成長，2020-2025年
  • 全球左心室輔助裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 經皮左心室輔助裝置，植入式左心室輔助裝置
  • 按流量類型
  • 搏動性和非搏動性
  • 透過使用
  • 復健橋樑療法 (BTR)、移植橋樑療法 (BTT)、終末治療、候選者橋樑療法 (BTC)
  • 最終用戶
  • 心臟病中心，醫院
  • 依類型細分：經皮左心室輔助裝置
  • 軸流式經皮左心室輔助裝置，離心式經皮左心室輔助裝置
  • 依類型細分：植入式左心室輔助裝置
  • 連續流裝置、脈動流裝置

第10章 區域與國家分析

  • 全球左心室輔助裝置市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球左心室輔助裝置市場：依國家、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 左心室輔助裝置市場：競爭格局與市場佔有率，2024 年
  • 左心室輔助裝置市場：公司估價矩陣
  • 左心室輔助裝置市場：公司概況
    • Abbott Laboratories
    • Medtronic plc
    • Terumo Corporation
    • St. Jude Medical
    • MAQUET GmbH & Co.

第37章：其他領先和創新企業

  • LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年左心室輔助裝置市場：提供新機會的國家
  • 2030年左心室輔助裝置市場：充滿新機會的細分市場
  • 2030年左心室輔助裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MLVAD01_G26Q1

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

Tariffs are impacting the left ventricular assist devices market by increasing costs of imported precision components, biocompatible materials, electronic controllers, and manufacturing equipment used in implantable and transcutaneous LVAD systems. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher production costs for export-oriented device manufacturing. These tariffs are increasing device pricing and procurement complexity for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier partnerships, and greater investment in domestic medical device production capabilities.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including left ventricular assist devices industry global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.73 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of advanced heart failure, limited availability of donor hearts, expansion of specialized cardiac care centers, improvements in surgical implantation techniques, rising clinical acceptance of mechanical circulatory support.

The left ventricular assist devices market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing aging population with cardiac conditions, rising demand for long-term heart failure management solutions, advancements in biocompatible materials, growing integration of remote monitoring technologies, expanding reimbursement coverage for lvads. Major trends in the forecast period include increasing adoption of continuous flow lvads, rising use of lvads as destination therapy, growing focus on miniaturized implantable pumps, expansion of remote patient monitoring capabilities, enhanced emphasis on device durability and longevity.

The increase in healthcare expenditures is expected to drive the growth of the left ventricular assist device market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare spending can facilitate the advancement and development of various health-related products, including left ventricular assist devices. As healthcare expenditures rise, they will positively impact the growth of the left ventricular assist device market. For example, in June 2025, data from the Centers for Medicare & Medicaid Services (CMS), a United States-based federal agency, indicated that national health spending rose by 7.5% in 2023 to reach $4.9 trillion, representing 17.6% of the United States gross domestic product. Thus, the rise in healthcare expenditures is propelling the growth of the left ventricular assist device market.

Companies active in the left ventricular assist devices space are increasingly concentrating on the development of next-generation technologies, including wave membrane-based systems, as alternatives to conventional rotary LVADs. Wave membrane solutions are designed to mimic natural cardiac pulsatility and blood flow dynamics, closely replicating the function of a healthy heart and potentially reducing complications associated with continuous-flow devices.For instance, in September 2025, CorWave SA, a France-based medical device company, successfully performed the first human implantation of its Left Ventricular Assisting System (LVAS) at St Vincent's Hospital in Sydney. The system delivered complete cardiac support by effectively unloading the left ventricle while maintaining an aortic pulse pressure of 25.5 +- 6.1 mmHg and enabling consistent aortic valve opening. The device met its primary study endpoints without any device-related adverse events at 30 days, and the patient subsequently underwent a successful heart transplant after 84 days of support. This development marks a significant advancement in durable mechanical circulatory support through the delivery of safe, physiological pulsatile blood flow.

In March 2025, Abbott Laboratories, a United States-based healthcare technology company, entered into a collaboration agreement with Cadrenal Therapeutics, Inc. for an undisclosed value. Through this partnership, Abbott sought to support Cadrenal in the execution of a pivotal clinical trial evaluating tecarfarin in patients implanted with HeartMate 3(TM) LVADs, thereby strengthening its role in advanced heart failure care and clinical research. Cadrenal Therapeutics, Inc. is a United States-based biopharmaceutical company focused on the development of novel anticoagulant therapies, including tecarfarin, specifically for patients using cardiovascular devices such as left ventricular assist devices.

Major companies operating in the left ventricular assist devices market are Abbott Laboratories, Medtronic plc, Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc.

North America was the largest region in the left ventricular assist devices market in 2025. The regions covered in the left ventricular assist devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Percutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
  • 2) By Type Of Flow: Pulsatile; Non-Pulsatile
  • 3) By Application: Bridge-To-Recovery (BTR) Therapy; Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Candidacy (BTC) Therapy
  • 4) By End-User: Cardiology Centers; Hospitals
  • Subsegments:
  • 1) By Percutaneous Left Ventricular Assist Devices: Axial-Flow Percutaneous LVADs; Centrifugal-Flow Percutaneous LVADs
  • 2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices; Pulsatile Flow Devices
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.; LivaNova Plc; Thoratec Corporation; Abiomed Inc; Berlin Heart GmbH; BioVentrix; Cleveland Heart Inc.; Jarvik Heart Inc.; CorWave SA; SynCardia Systems LLC; NuPulseCV Inc.; Fineheart; Procyrion Inc; Carmat SA; BiVACOR Inc; Cardiac Assist Inc.; Leviticus Cardio Ltd.; Calon Cardio-Technology Ltd; Evaheart Inc.; Sunshine Heart Inc.; CH Biomedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Left Ventricular Assist Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Left Ventricular Assist Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Left Ventricular Assist Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Left Ventricular Assist Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Continuous Flow Lvads
    • 4.2.2 Rising Use Of Lvads As Destination Therapy
    • 4.2.3 Growing Focus On Miniaturized Implantable Pumps
    • 4.2.4 Expansion Of Remote Patient Monitoring Capabilities
    • 4.2.5 Enhanced Emphasis On Device Durability And Longevity

5. Left Ventricular Assist Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiology Centers
  • 5.3 Cardiac Specialty Clinics
  • 5.4 Heart Transplant Centers
  • 5.5 Advanced Heart Failure Clinics

6. Left Ventricular Assist Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Left Ventricular Assist Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Left Ventricular Assist Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Left Ventricular Assist Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Left Ventricular Assist Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Left Ventricular Assist Devices Market Segmentation

  • 9.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
  • 9.2. Global Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pulsatile, Non-Pulsatile
  • 9.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bridge-To-Recovery (BTR) Therapy, Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy
  • 9.4. Global Left Ventricular Assist Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiology Centers, Hospitals
  • 9.5. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Percutaneous Left Ventricular Assist Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Axial-Flow Percutaneous LVADs, Centrifugal-Flow Percutaneous LVADs
  • 9.6. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Implantable Left Ventricular Assist Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Flow Devices, Pulsatile Flow Devices

10. Left Ventricular Assist Devices Market Regional And Country Analysis

  • 10.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Left Ventricular Assist Devices Market

  • 11.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Left Ventricular Assist Devices Market

  • 12.1. China Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Left Ventricular Assist Devices Market

  • 13.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Left Ventricular Assist Devices Market

  • 14.1. Japan Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Left Ventricular Assist Devices Market

  • 15.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Left Ventricular Assist Devices Market

  • 16.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Left Ventricular Assist Devices Market

  • 17.1. South Korea Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Left Ventricular Assist Devices Market

  • 18.1. Taiwan Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Left Ventricular Assist Devices Market

  • 19.1. South East Asia Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Left Ventricular Assist Devices Market

  • 20.1. Western Europe Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Left Ventricular Assist Devices Market

  • 21.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Left Ventricular Assist Devices Market

  • 22.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Left Ventricular Assist Devices Market

  • 23.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Left Ventricular Assist Devices Market

  • 24.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Left Ventricular Assist Devices Market

  • 25.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Left Ventricular Assist Devices Market

  • 26.1. Eastern Europe Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Left Ventricular Assist Devices Market

  • 27.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Left Ventricular Assist Devices Market

  • 28.1. North America Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Left Ventricular Assist Devices Market

  • 29.1. USA Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Left Ventricular Assist Devices Market

  • 30.1. Canada Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Left Ventricular Assist Devices Market

  • 31.1. South America Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Left Ventricular Assist Devices Market

  • 32.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Left Ventricular Assist Devices Market

  • 33.1. Middle East Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Left Ventricular Assist Devices Market

  • 34.1. Africa Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Left Ventricular Assist Devices Market Regulatory and Investment Landscape

36. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

  • 36.1. Left Ventricular Assist Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Left Ventricular Assist Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Left Ventricular Assist Devices Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

37. Left Ventricular Assist Devices Market Other Major And Innovative Companies

  • LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc.

38. Global Left Ventricular Assist Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

40. Left Ventricular Assist Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Left Ventricular Assist Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Left Ventricular Assist Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Left Ventricular Assist Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer